Nasal Drug Delivery on the Rise: What’s Next for Pharma?

Join us to discover how to drive innovation and deliver impactful solutions in this rapidly evolving field. This session will provide actionable insights and a forward-looking perspective on evolving opportunities in nasal drug development and delivery.

Register Free: https://www.pharmtech.com/pt_w/nasal-drug-delivery

Event Overview:

Nasal drug delivery is rapidly becoming a transformative approach in the pharmaceutical industry, offering unique advantages for both patients and drug developers. With applications spanning small molecules, biologics, and vaccines, nasal delivery systems are being leveraged to overcome challenges in drug administration, enhance therapeutic efficacy, and improve patient adherence.

In this webinar, experts will provide a comprehensive overview of the nasal drug delivery market, highlighting key trends and the evolving landscape driving innovation. Attendees will gain insights into pipeline advancements, the growing adoption of nasal delivery for biologics, and the rise of nasal powder formulations as a stable and patient-friendly solution. Additionally, the speakers will discuss future innovations, including cutting-edge devices and emerging technologies that promise to redefine the field.

Join us to discover how to drive innovation and deliver impactful solutions in this rapidly evolving field. This session will provide actionable insights and a forward-looking perspective on evolving opportunities in nasal drug development and delivery.

Key Learning Objectives:

• Understand the current market landscape for nasal drug delivery, including key trends and pipeline developments
• Explore the unique advantages of nasal delivery for biologics and nasal powders in enhancing drug stability and patient adherence
• Discover future innovations in nasal delivery systems, including advancements in device design and formulation technologies

Speakers:

Mark Ignaczak
Director, Innovation and Partnerships – Nasal Delivery
Catalent

Mark Ignaczak, director of innovation and partnerships for nasal delivery at Catalent. Ignaczak leads strategic growth initiatives and partnerships for Catalent’s nasal liquid and powder business and has an extensive background in nasal spray product development and commercialization. He holds a bachelor of science in biochemical engineering from Rutgers, New Brunswick, New Jersey. Mark has 21 years of pharmaceutical experience and over 17 years of direct experience with nasal spray products. In that time, he has worked on 75+ nasal programs in varying stages within the project lifecycle, ultimately launching 10+ NDAs, some considered first-of-their-kind and best-in-class therapies. Throughout his career, he has fulfilled various roles within bioprocess engineering, product development, supply chain, packaging, and all aspects of nasal delivery program management and strategy.

Ryan Doxey
Vice President, Technical Services
Kymanox

Ryan Doxey, with over 20 years of industry experience, Ryan Doxey is a seasoned, strategic leader in the areas of CMC-regulatory and pharmaceutical/biologics development. Doxey’s expertise includes pharmaceutical and biopharmaceutical product development (formulation, process, analytical), US and ROW/global CMC regulatory strategy, technology transfer (pre- and post-approval), CDMO/CMO selection and management, program and portfolio management, and clinical supply manufacturing, labeling, and distribution. He has a specialty and passion for identifying, developing, and delivering practical and innovative solutions for complex, nonconventional product formulations and drug delivery systems from concept to pivotal clinical studies. Doxey has supported numerous clients in nasal drug delivery development, including considerations for device selection, manufacturing process design and development, and regulatory compliance.

Register Free: https://www.pharmtech.com/pt_w/nasal-drug-delivery